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Background: Insulin resistance (IR) reduces reactivity of the target organ to blood insulin. Researchers have
attempted to evaluate IR using various serum lipid concentration ratios. We aimed to determine the most strongly
IR-predictive lipid profile ratios for each sex by studying associations between lipid concentration ratios and IR using
data from the fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1) 2010.
Methods: Overall, 8958 individuals participated in health interview and examination surveys. Among them, 1910
individuals who completed physical examinations and 8-h fasting blood tests and were older than 20 years of age
were enrolled (929 men and 981 women). The lipid-ratio-related study outcomes were the low-density lipoprotein
cholesterol/high-density lipoprotein cholesterol (LDL-C/HDL-C), triglyceride (TG)/HDL-C, and non-HDL-C (LDL-C +
TG/5)/HDL-C ratios. We divided subjects into 4 groups according to lipid profile ratio quartiles for a comparison of
homeostasis model assessment (HOMA)-IR values. Regression analyses were performed after adjusting for the
confounding factors of age, body mass index, and diabetes mellitus history.
Results: HOMA-IR values tended to increase significantly along with LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C
ratios in both sexes. In men, multiple linear regression analyses showed that after adjusting for confounding factors, a
significant positive association remained only with the LDL-C/HDL-C ratio (p= 0.0238, R2 = 0.3605, root mean squared
error [MSE] =0.3512). In women, multiple linear regression analyses showed that after adjusting for confounding factors,
significant positive associations remained with the LDL-C/HDL-C (p < 0.0001, R-square = 0.2329, root MSE = 0.3776),
TG/HDL-C (p = 0.0001, R2 = 0.2373, root MSE = 0.3766), and non-HDL-C/HDL-C ratios (p < 0.0001, R2 = 0.2456, root
MSE = 0.3745).
Conclusion: The LDL-C/HDL-C ratio in men and LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios in women might
be clinically significant predictors of IR in healthy Korean adults. However, additional large-scale studies are required to
confirm these findings.
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Insulin resistance (IR) is a condition in which the reactivity
of a target organ to blood insulin is reduced, and is known
to be the strongest predictor of type 2 diabetes mellitus oc-
currence [1]. IR is considered a core causal factor of hyper-
tension, obesity, coronary artery disease, dyslipidemia, and
metabolic syndrome [2] and is therefore actively studied
worldwide.
IR can result from various genetic or acquired causes, in-
cluding obesity, body fat distribution, reduced physical ac-
tivity, malnutrition at birth, aging, pregnancy, drug use,
chronic hyperglycemia, mitochondrial malfunction, inflam-
mation, and stress [3–7]. In 1985, Matthews et al. first
described the homeostasis model assessment for IR
(HOMA-IR) as a useful and accurate method for IR
quantification [8]. Since then, several clinicians have
researched these data and found HOMA-IR to be a reli-
able marker of IR [9, 10].
Recently, researchers have actively attempted to evalu-
ate IR using ratios of various serum lipid concentration
levels, such as the total cholesterol/high-density lipopro-
tein cholesterol (HDL-C), low-density lipoprotein chol-
esterol (LDL-C)/HDL-C, and triglyceride (TG)/HDL-C
ratios [11–14]. In addition, previous studies have sug-
gested independent associations between IR and the
LDL-C/HDL-C [13], TG/HDL-C, and total cholesterol
(TC)/HDL-C ratios [11, 12, 14].
The serum concentrations of lipids differ according to
sex [15, 16]. However, previous studies have evaluated
data without distinguishing male and female subjects.
We hypothesized that the strongest predictors of IR
might differ between men and women. In the present
study, we determined which lipid profile ratio served as
the strongest IR predictive index for each sex by study-
ing the associations between lipid profile ratios (e.g.,
LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C)
and IR in Korean adults randomly selected from the
Korea National Health and Nutrition Examination Sur-
vey (KNHANES) 2010.
Methods
Subjects and data collection
This study analyzed data from the fifth KNHANES
(KNHANES V-1), a cross-sectional and nationally represen-
tative survey conducted by the Division of Chronic Disease
Surveillance of the Korean Center for Disease Control and
Prevention. KNHANES V-1 comprised 4 different surveys
designed to evaluate the general health and nutrition status
of the Korean population; these included a health interview
survey, health behavior survey, health examination survey,
and nutrition survey. During KNHANES V-1 2010, 8958 in-
dividuals participated in the health interview and health
examination surveys. Among them, 1910 people older than
20 years of age who completed physical examinations and8-h fasting blood tests were selected for the present study
(929 men, 981 women). Subjects with missing data were
excluded.
Health interviews and physical examinations were con-
ducted at mobile exam centers, and nutrition surveys were
conducted during visits to subjects’ households. Regarding
drinking, the subjects were asked if they had not drunk any
alcohol throughout their lives or if they had drunk at least 1
glass per month during the previous 1-year period. Regard-
ing exercise, the subjects were asked to answer whether or
not they had performed at least 3 sessions of very intense
physical activity per week for 20 min or more per session or
whether they had performed at least 5 sessions of moderate
physical activity per week for 30 min or more per session.
Physical measurements
Body mass index (BMI) was calculated by dividing the
body weight (kg) by the height squared (m2). Waist cir-
cumference was measured during normal breathing at the
center point between the lowest rib and pelvic iliac crest.
Blood pressure was measured after the subjects had been
seated for a 10-min rest period. Three systolic and dia-
stolic blood pressure readings were recorded with a 5-min
interval, and the average value was used for analysis.
Anthropometric and laboratory parameter measurements
Plasma glucose and insulin levels after fasting for 8 h or
more, as well as total cholesterol, TG, HDL-C, and LDL-C
levels, were measured using a Hitachi Automatic Analyzer
7600 (Hitachi, Ltd., Tokyo, Japan). Glycated hemoglobin
levels were measured using an HLC-723G7 auto analyzer
(Tosoh Corporation, Minato, Japan). Blood samples were
centrifuged, refrigerated at the examination site, and trans-
ferred in iceboxes to a central laboratory in Seoul on the
day of collection.
IR index
The IR index was calculated using the relatively simple and
highly validated homeostasis model assessment (HOMA)-
IR [8] as follows:
HOMA‐IR ¼ glucose mg=dLð Þ
 insulin uIU=mLð Þ=405
Statistical analysis
All analyses were performed separately for each sex. The
KNHANES V-1 database sample used in this study was
extracted via stratified, clustered, and systematic sampling.
We considered strata, clusters, and weights in the statis-
tical analysis. The SURVEYMEANS procedure was used
to calculate averages and ratios, and the SURVEYREG and
SURVEYFREQ procedures were used in the association
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We used the LDL-C/HDL-C, TG/HDL-C, and non-
HDL-C (LDL + TG/5)/HDL-C ratios as lipid
concentration-ratio-related outcomes in the present
study. We divided subjects into 4 groups according to
lipid profile ratio quartiles to allow comparisons of
HOMA-IR values. In the regression analysis, we adjusted
for the confounding factors of age, BMI, waist circum-
ference, and medical history of diabetes mellitus; Log
(HOMA-IR) values were used because of the abnormal
distribution of HOMA-IR values.
All statistical analyses were performed using SAS ver-
sion 9.2 (SAS Institute, Cary, NC, USA), and significance
was defined as a p-value < 0.05.
This study protocol conforms to the ethical guidelines
of the 1975 Declaration of Helsinki as reflected in a
priori approval by the Korea Centers for Disease Control
and Prevention institutional review board in Korea (No.
2010-02CON-21-C).Results
Baseline characteristics
The mean ages of the male and female subjects were
40.80 (95 % confidence interval (CI), 39.79–41.80) and
41.45 (95 % CI, 40.63–42.26) years, respectively. The
mean LDL-C/HDL-C ratios were 2.40 (95 % CI, 2.33–
2.46) for men and 2.04 (95 % CI, 1.99–2.09) for women.
The mean TG/HDL-C ratios were 3.69 (95 % CI, 3.20–
4.18) for men and 2.06 (95 % CI, 1.95–2.17) for women.
The mean non-HDL-C/HDL-C ratios were 6.09 (95 %
CI, 5.58–6.59) for men and 4.10 (95 % CI, 3.95–4.24) for
women. The mean HOMA-IR values were 2.58 (95 %
CI, 2.44–2.71) for men and 2.52 (95 % CI, 2.39–2.64) for
women. There were significant differences between men
and women in terms of smoking status, alcohol con-
sumption, and physical activity. These results suggest
that the men and women enrolled in this study experi-
enced different lifestyles, with considerable influences on
serum cholesterol levels [17, 18] (Table 1).Mean comparison of HOMA-IR values among LDL-C/HDL-
C, TG/HDL-C, and non-HDL-C/HDL-C ratio quartile groups
We divided the subjects into sets of 4 quartile groups ac-
cording to the LDL-C/HDL-C ratio (first, second, third,
and fourth quartile groups:<1.64000, 1.64000–2.15895,
2.15895–2.78788, and ≥ 2.78788, respectively), TG/HDL-
C ratio (first, second, third, and fourth quartile
groups:<1.25581, 1.25581–2.04302, 2.04302–3.50000,
and ≥ 3.50000, respectively), and non-HDL-C/HDL-C ra-
tio (first, second, third, and fourth quartile
groups:<3.07042, 3.07042–4.28846, 4.28846–6.31818,
and ≥ 6.31818, respectively) (Table 2).Statistically significant differences were observed
within each sex among all 3 sets of quartile groups
(mean LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/
HDL-C ratios; p-values were obtained via the SURVEY-
MEANS procedure). In both sexes, HOMA-IR values
tended to increase as the LDL-C/HDL-C, TG/HDL-C,
and non-HDL-C/HDL-C ratios increased.
Multiple linear regression model of log transformed
HOMA-IR values in men
Table 3 lists the results of analytical evaluations of the
associations of individual lipid measure ratios (LDL-C/
HDL-C ratio, TG/HDL-C ratio and non-HDL-C/HDL-C
ratio) with HOMA-IR according to a multiple linear re-
gression test. In men, multiple linear regression analyses
revealed that after adjusting for the confounding factors
of age, BMI, and medical history of diabetes mellitus, a
significant positive association was only observed with
the LDL-C/HDL-C ratio (p-value = 0.0238, adjusted R2 =
0.3588, root mean square error [MSE] =0.3512).
Multiple linear regression model of log transformed
HOMA-IR values in women
In women, multiple linear regression analyses showed
that after adjusting for the confounding factors of age,
BMI, and medical history of diabetes mellitus, significant
positive associations were observed with the LDL-C/
HDL-C ratio (p-value <0.0001, adjusted R2 = 0.2309, root
MSE = 0.3776), TG/HDL-C ratio (p-value = 0.0001, ad-
justed R2 = 0.2353, root MSE = 0.3766), and non-HDL-
C/HDL-C ratio (p-value < 0.0001, adjusted R2 = 0.2437,
root MSE = 0.3745) (Table 3).
Discussion
This study was performed to evaluate sex-based associa-
tions between lipid concentration ratios (e.g., LDL-C/
HDL-C, TG/HDL-C, and non-HDL-C/HDL-C) and
HOMA-IR values in order to determine the strongest
predictor of IR in each sex. According to the results,
only the LDL-C/HDL-C ratio was significantly and posi-
tively associated with HOMA-IR values in men. On the
other hand, the LDL-C/HDL-C (p-value < 0.0001, ad-
justed R2 = 0.2309, root MSE = 0.3776), TG/HDL-C (p-
value = 0.0001, adjusted R2 = 0.2353, root MSE = 0.3766),
and non-HDL-C/HDL-C ratios (p-value < 0.0001, ad-
justed R2 = 0.2437, root MSE = 0.3745) were all signifi-
cantly and positively associated with HOMA-IR values
in women.
In most cases, patients with IR have hypertriglyc-
eridemia and low HDL-C levels because insulin affects
the metabolism of very low-density lipoprotein choles-
terol (VLDL-C) and HDL-C [19]. Systemically circulat-
ing insulin inhibits the secretion of VLDL-C and
stimulates the activation of lipoprotein lipase (LPL).
Table 1 Baseline characteristics
Men Women p-value
N Mean Lower C.I. Upper C.I. N Mean Lower C.I. Upper C.I.
Age (years) 929 40.80 39.79 41.80 981 41.45 40.63 42.26 0.2137
Height (cm) 929 171.50 170.93 172.07 981 158.40 157.95 158.85 <0.0001
Weight (kg) 929 71.30 70.38 72.22 981 57.75 57.04 58.47 <0.0001
BMI (kg/m2) 929 24.19 23.94 24.44 981 23.07 22.75 23.39 <0.0001
Waist Circumference (cm) 922 84.08 83.38 84.77 972 76.82 76.01 77.63 <0.0001
HDL-C (mg/dL) 929 49.90 48.91 50.89 981 56.77 55.85 57.70 <0.0001
LDL-C (mg/dL) 929 112.93 110.56 115.29 981 109.53 107.04 112.01 0.0518
Total Cholesterol (mg/dL) 929 187.02 184.09 189.95 981 184.53 181.56 187.50 0.2129
TG (mg/dL) 929 159.42 145.77 173.07 981 105.72 100.98 110.46 <0.0001
LDL-C/HDL-C Ratio 929 2.40 2.33 2.46 981 2.04 1.99 2.09 <0.0001
TG/HDL-C Ratio 929 3.69 3.20 4.18 981 2.06 1.95 2.17 <0.0001
Non-HDL-C (mg/dL) 929 272.35 258.69 286.00 981 215.25 209.32 221.17 <0.0001
Non-HDL-C/HDL-C Ratio 929 6.09 5.58 6.59 981 4.10 3.95 4.24 <0.0001
SBP (mmHg) 929 118.59 117.41 119.76 981 112.61 111.49 113.74 <0.0001
DBP (mmHg) 929 77.65 76.65 78.66 981 71.87 71.11 72.64 <0.0001
Fasting Glucose (mg/dL) 929 98.67 96.33 101.01 981 93.31 92.11 94.52 <0.0001
Fasting Insulin (uIU/mL) 929 10.46 10.00 10.91 981 10.69 10.32 11.06 0.4121
HOMA-IR 929 2.58 2.44 2.71 981 2.52 2.39 2.64 0.5048
N % Lower C.I. Upper C.I. N % Lower C.I. Upper C.I.
Hypertension 0.3511
No 729 84.48 82.10 86.85 796 85.92 83.96 87.88
Yes 190 15.52 13.15 17.90 180 14.08 12.12 16.04
Hyperlipidemia 0.9149
No 833 92.51 90.47 94.55 867 92.63 90.97 94.30
Yes 85 7.49 5.45 9.53 109 7.37 5.70 9.03
Diabetes 0.1617
No 842 93.53 91.79 95.27 920 95.22 93.69 96.75
Yes 76 6.47 4.73 8.21 56 4.78 3.25 6.31
Smoking <0.0001
No 496 50.66 46.71 54.62 928 94.58 92.81 96.35
Yes 426 49.34 45.38 53.30 50 5.42 3.65 7.19
Alcohol Use <0.0001
No 192 20.59 17.48 23.69 587 55.83 51.53 60.12
Yes 722 79.41 76.31 82.52 384 44.17 39.88 48.47
Exercise: high <0.0001
No 730 77.47 74.01 80.93 855 87.11 84.29 89.94
Yes 191 22.53 19.07 26.00 121 12.89 10.06 15.71
Exercise: mid 0.0798
No 817 87.19 84.46 89.93 876 90.01 87.86 92.17
Yes 105 12.81 10.07 15.54 100 9.99 7.83 12.14
p-values were calculated using the SURVEYMEANS (for continuous values) and SURVEYFREQ procedures (for categorical values)
BMI Body mass index, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, SBP Systolic blood pressure, DBP Diastolic blood
pressure, HOMA-IR Homeostasis model assessment of insulin resistance, C.I. Confidence interval
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Table 2 Mean comparison of HOMA-IR values among LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratio quartile groups
(A) Men 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile p-value
LDL-C/HDL-Ca N = 183 N = 210 N = 251 N = 285
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 2.23 2.09 2.37 2.51 2.08 2.94 2.54 2.34 2.74 2.90 2.67 3.14 <0.0001
Log (HOMA-IR) 0.72 0.66 0.79 0.78 0.69 0.87 0.83 0.77 0.90 0.95 0.89 1.02 <0.0001
TG/HDL-Cb N = 137 N = 200 N = 257 N = 335
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 1.99 1.80 2.17 2.29 2.10 2.48 2.46 2.26 2.67 3.13 2.83 3.43 <0.0001
Log (HOMA-IR) 0.63 0.56 0.70 0.74 0.68 0.81 0.80 0.73 0.86 1.02 0.97 1.08 <0.0001
Non-HDL-C/HDL-Cc N = 146 N = 204 N = 241 N = 338
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 1.99 1.82 2.17 2.23 2.07 2.40 2.59 2.38 2.81 3.08 2.77 3.40 <0.0001
Log (HOMA-IR) 0.62 0.55 0.69 0.73 0.67 0.79 0.85 0.78 0.91 1.00 0.94 1.07 <0.0001
(B) Women 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile p-value
LDL-C/HDL-Cd N = 294 N = 268 N = 228 N = 191
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 2.14 2.00 2.28 2.37 2.21 2.54 2.56 2.38 2.74 3.44 2.90 3.97 <0.0001
Log (HOMA-IR) 0.69 0.63 0.75 0.78 0.72 0.84 0.86 0.79 0.92 1.06 0.97 1.15 <0.0001
TG/HDL-Ce N = 341 N = 277 N = 220 N = 143
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 2.23 2.03 2.44 2.28 2.16 2.41 2.64 2.45 2.83 3.61 3.10 4.13 <0.0001
Log (HOMA-IR) 0.70 0.65 0.76 0.75 0.70 0.81 0.87 0.80 0.94 1.16 1.07 1.25 <0.0001
non-HDL-C/HDL-Cf N = 332 N = 275 N = 233 N = 141
Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I Mean Lower C.I Upper C.I
HOMA-IR 2.15 2.00 2.30 2.29 2.17 2.41 2.77 2.44 3.09 3.64 3.10 4.18 <0.0001
Log (HOMA-IR) 0.69 0.63 0.75 0.76 0.71 0.81 0.89 0.82 0.96 1.16 1.06 1.26 <0.0001
p-values were obtained via the SURVEYMEANS procedure
LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, TG Triglyceride, HOMA-IR Homeostasis model assessment of insulin resist-
ance, C.I. Confidence interval
a1st quartile group (<1.64000), 2nd quartile group (1.64000–2.15895), 3rd quartile group (2.15895–2.78788), 4th quartile group (≥2.78788)
b1st quartile group (<1.25581), 2nd quartile group (1.25581–2.04302), 3rd quartile group (2.04302–3.50000), 4th quartile group (≥3.50000)
c1st quartile group (<174), 2nd quartile group (174–223), 3rd quartile group (223–291), 4th quartile group (≥291)
d1st quartile group (<1.64000), 2nd quartile group (1.64000–2.15895), 3rd quartile group (2.15895–2.78788), 4th quartile group (≥2.78788)
e1st quartile group (<1.25581), 2nd quartile group (1.25581–2.04302), 3rd quartile group (2.04302–3.50000), 4th quartile group (≥3.50000)
f1st quartile group (<3.07042), 2nd quartile group (3.07042–4.28846), 3rd quartile group (4.28846–6.31818), 4th quartile group (≥6.31818)
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liver, thus increasing apolipoprotein B levels via in-
creased fat generation, increasing VLDL-C secretion,
and decreasing the concentration and activity of LPL in
peripheral tissues, especially adipose tissue. Ultimately,
the decrease in HDL-C levels occurs as a secondary
process following an increase in TG [20].
Many previous studies have suggested various lipid ra-
tios as simple and useful parameters for determining IR.
For example, when TG levels and TG/HDL-C ratios
were compared and analyzed in 50 Caucasian Ameri-
cans, the areas under the receiver-operating characteris-
tic curves (AUCs) were 0.763 and 0.770, respectively,
suggesting that the TG/HDL-C ratio was a significant
predictor of IR. However, the significance of this ratiowas low among African-Americans [11]. In another study
in which the TG/HDL-C and total cholesterol/HDL-C ra-
tios were compared in 2,014 patients, the TG/HDL-C ratio
was reported to be an imperfect but statistically significant
(AUC= 0.745, p-value < 0.001) predictor of the risks of IR
and coronary artery disease [12]. According to a recent ana-
lysis of 1,393 Japanese subjects, the LDL-C/HDL-C ratio
was found to be a significant predictor of IR among non-
obese subjects (AUC= 0.74, p-value < 0.001), with a cut-off
value of 2.14 [13]. Therefore, the best lipid profile ratio for
predicting IR remains controversial.
We focused on sex-based differences to determine the
most IR-predictive lipid profile ratios. One previous study
suggested that women and men have significantly different
lipid, apoprotein, and lipoprotein values (lower BMI, TG,
Table 3 Results of the multiple linear regression model for log transformed HOMA-IR
Men Women
Estimate Standard error p-value Adjusted R2 Root MSE Estimate Standard error p-value Adjusted R2 Root MSE
Model with LDL-
C/HDL-C
0.3588 0.3512 0.2309 0.3776
Age −0.0010 0.0012 0.3953 −0.0027 0.0013 0.0451
BMI 0.0429 0.0086 <0.0001 0.0247 0.0100 0.0149
Waist
Circumference
0.0101 0.0028 0.0007 0.0066 0.0039 0.0919
Diabetesa 0.3911 0.0621 <0.0001 0.3578 0.1014 0.0005
LDL-C/HDL-C
Ratio
0.0383 0.0168 0.0238 0.1015 0.0242 <0.0001
Model with TG/
HDL-C
0.3641 0.3497 0.2353 0.3766
Age −0.0010 0.0013 0.4126 −0.0025 0.0013 0.0529
BMI 0.0445 0.0083 <0.0001 0.0256 0.0101 0.010
Waist
Circumference
0.0097 0.0029 0.0009 0.0065 0.0042 0.1206
Diabetesa 0.3868 0.0635 <0.0001 0.3415 0.0998 0.0008
TG/HDL-C Ratio 0.0086 0.0070 0.2222 0.0485 0.0124 0.0001
Model with non-
HDL-C/HDL-C
0.3662 0.3491 0.2437 0.3745
Age −0.0011 0.0013 0.3690 −0.0030 0.0013 0.0224
BMI 0.0439 0.0084 <0.0001 0.0242 0.0100 0.0164
Waist
Circumference
0.0096 0.0029 0.0009 0.0060 0.0041 0.1421
Diabetesa 0.3898 0.0632 <0.0001 0.3394 0.0969 0.0006
Non-HDL-C/
HDL-C Ratio
0.0091 0.0069 0.1907 0.0448 0.0095 <0.0001
p-values were evaluated using the SURVEYMEANS procedure (LDL-C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios were treated as continuous values)
R2 Root-square, Root MSE Root mean squared error, HOMA-IR Homeostasis model assessment of insulin resistance, LDL-C/HDL-C Low-density lipoprotein
cholesterol/high-density lipoprotein cholesterol ratio, TG/HDL-C Triglyceride/high-density lipoprotein cholesterol ratio, non-HDL-C/HDL-C Non-high-density
lipoprotein cholesterol (LDL-C + triglyceride)/HDL-C ratio, BMI Body mass index
aDiabetes was defined as a medical history of diabetes mellitus
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HDL-C values in women vs. men) [21]. Another study also
suggested that women have higher apolipoproteinA-I pro-
duction rates, compared with men [22]. The results of the
present study support these previously reported differ-
ences (Table 3). In the present study, women had signifi-
cantly lower BMI and TG values and significantly higher
HDL-C values. Therefore, we performed a multiple re-
gression analysis of each lipid profile ratio in each sex.
The present study has the following strengths. In this
study, the best predictor of IR was examined in each
sex, an investigation that has not been previously re-
ported. Accordingly, only the LDL-C/HDL-C ratio was
found to be significantly associated with HOMA-IR
values in men, whereas a regression model revealed that
the LDL-C/HDL-C, TG/HDL-C, non-HDL-C/HDL-C
ratios were clinically significant in women. In addition,
as only 6.91 % (132) of the subjects had a medical his-
tory of diabetes mellitus, the results of the present studycan be fully applied to healthy adult Korean groups in
clinical settings.
The limitations of this study are as follows. First, as this
was a cross-sectional study based on data from KNHANES
2010, inaccurate information and recall errors might have
been introduced through the interview methods and self-
administered questionnaires. Second, as other risk factors of
IR such as family history, medical history of gestational dia-
betes mellitus, or presence of an inflammatory reaction were
not considered, these might have affected the outcomes. Fi-
nally, cut-off values for the lipid profile ratios found to be
optimum predictors of IR could not be determined in this
study; this issue will require further evaluation in an add-
itional large-scale study in the future.
Conclusions
We suggest that the LDL-C/HDL-C ratio and the LDL-
C/HDL-C, TG/HDL-C, and non-HDL-C/HDL-C ratios
could be clinically significant predictors of IR in healthy
Byun et al. Diabetology & Metabolic Syndrome  (2015) 7:59 Page 7 of 7adult men and women, respectively. However, additional
large-scale studies will be required to evaluate the
optimum cut-off values for the lipid profile ratios used
to determine IR in each sex.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ARB and KWS conceived and conducted the study and analyzed data. SWL
and HSL were involved in manuscript drafting or critical revision of
important intellectual content. All authors were involved in writing the paper
and had final approval of the submitted and published versions.
Funding
No financial support was received during the present study.
Received: 5 March 2015 Accepted: 12 June 2015
References
1. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin
resistance and insulin secretory dysfunction as precursors of non-insulin-
dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J
Med. 1993;329:1988–92.
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human
disease. Diabetes. 1988;37:1595–607.
3. McNeal C, Wilson DP. Metabolic syndrome and dyslipidemia in youth. J Clin
Lipidol. 2008;2:147–55.
4. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance.
Diabetologia. 2003;46:1594–603.
5. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship
between degree of obesity and in vivo insulin action in man. Am J Physiol.
1985;248:E286–91.
6. Hales CN, Barker DJ. Type 2(non-insulin-dependent) diabetes mellitus: the
thrifty phenotype hypothesis. Diabetologia. 1992;35:595–601.
7. Turner N, Heibronn LK. Is mitochondrial dysfunction a cause of insulin
resistance? Trends Endocrinol Metabol. 2008;19:324–30.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.
Homeostasis model assessment: insulin resistance and beta-cell function
from fasting plasma glucose and insulin concentration in man. Diabetologia.
1985;28:412–9.
9. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between
several surrogates estimates of insulin resistance and quantification of
insulin-mediated glucose disposal in 490 healthy non diabetic volunteers.
Diabetes Care. 2000;23:171–5.
10. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling.
Diabetes Care. 2004;27:1487–95.
11. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should
triglyceride and the triglyceride to high-density lipoprotein cholesterol ratio
be used as surrogates for insulin resistance? Metabolism. 2010;59:299–304.
12. Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ. Usefulness of the
triglyceride-high-density lipoprotein versus the cholesterol-high-density lipo-
protein ratio for predicting insulin resistance and cardiometabolic risk (from
the Framingham Offspring Cohort). Am J Cardiol. 2008;101:497–501.
13. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. Low-
density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio
is the best surrogate marker for insulin resistance in non-obese Japanese
adults. Lipids Health Dis. 2010;9:138–43.
14. Jeppesen J, Facchini FS, Reaven GM. Individuals with high total cholesterol/
HDL cholesterol ratios are insulin resistant. J Intern Med. 1998;243:293–8.
15. Phillips NR, Havel RJ, Kane JP. Sex-related differences in the concentrations
of apolipoprotein E in human blood plasma and plasma lipoproteins. J Lipid
Res. 1983;24:1525–31.
16. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein
metabolism: it’s not just about sex hormones. J Clin Endocrinol Metab.
2011;96:885–93.
17. Look AHEAD, Group R, Wing RR. Long-term effects of a lifestyle intervention
on weight and cardiovascular risk factors in individuals with type 2 diabetesmellitus: four-year results of the Look AHEAD trial. Arch Intern Med.
2010;170:1566–75.
18. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, et al.
Effect of lifestyle modification on adipokine levels in obese subjects with
insulin resistance. Obes Res. 2003;11:1048–54.
19. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute
hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal
weight and obese individuals. Diabetes. 1993;42:833–42.
20. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signaling pathways:
insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85–96.
21. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM, et al. Effects of
gender and menopausal status on plasma lipoprotein subspecies and
particle sizes. J Lipid Res. 1996;37:1886–96.
22. Schaefer EJ, Foster DA, Zech LA, Lindgren FT, Brewer Jr HB, Levy RI. The
effects of estrogen administration on plasma lipoprotein metabolism in
premenopausal females. J Clin Endocrinol Metab. 1983;57:262–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
